Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Arginine hydrochloride 5.0% in 500 mL Solution for infusion, bottle McGaw Biomed Limited, Point Chevalier, Auckland Desferrioxamine mesylate 500 mg Powder for injection, vial David Bull Laboratories Limited, Mulgrave North, Victoria, Australia Sodium fluoride 2.73% w/w Gel, topical, bottle Pascal Company Inc., Bellevue, Washington, United States of America 60 Second Taste (Apple Cinnamon flavour) Sodium fluoride 2.73% w/w Gel, topical, bottle Pascal Company Inc., Bellevue, Washington, United States of America 60 Second Taste (Bubblegum flavour) Sodium fluoride 2.73% w/w Gel, topical, bottle Pascal Company Inc., Bellevue, Washington, United States of America 60 Second Taste (Grape flavour) Sodium fluoride 2.73% w/w Gel, topical, bottle Pascal Company Inc., Bellevue, Washington, United States of America 60 Second Taste (Mint flavour) Sodium fluoride 2.73% w/w Gel, topical, bottle Pascal Company Inc., Bellevue, Washington, United States of America 60 Second Taste (Orange Twist flavour) Sodium fluoride 2.73% w/w Gel, topical, bottle Pascal Company Inc., Bellevue, Washington, United States of America 60 Second Taste (Raspberry flavour) Sodium fluoride 2.73% w/w Gel, topical, bottle Pascal Company Inc., Bellevue, Washington, United States of America 60 Second Taste (Strawberry flavour) Sodium fluoride 0.685%, stannous fluoride 1.64% Solution, topical Pascal Company Inc., Bellevue, Washington, United States of America 60:60 Rinse (Bubblegum flavour) Sodium fluoride 0.685%, stannous fluoride 1.64% Solution, topical Pascal Company Inc., Bellevue, Washington, United States of America 60:60 Rinse (Mint flavour) Sodium fluoride 0.685%, stannous fluoride 1.64% Solution, topical Pascal Company Inc., Bellevue, Washington, United States of America 60:60 Rinse (Raspberry flavour) Sodium bicarbonate 750 g, 1000 g Powder, cartridge Althin Medical AB., Ronneby, Sweden Altracart II Methadone hydrochloride 2 mg/mL in 100 mL, 200 mL, 500 mL Solution, oral McGaw Biomed Limited, Point Chevalier, Auckland Biodone Ispaghula husk 100% Powder, oral, bottles (300 g, 450 g) Powder, sachets (6 g) Konsyl Pharmaceuticals Inc., Easton, Maryland, United States of America Konsyl (sugar and flavour free) Ispaghula husk 28% Powder, oral, bottles (538 g) Powder, sachets (12 g) Konsyl Pharmaceuticals Inc., Easton, Maryland, United States of America Konsyl Orange (sucrose) Ispaghula husk 58.60% Powder, oral, bottles (425 g) Powder, sachets (5.8 g) Konsyl Pharmaceuticals Inc., Easton, Maryland, United States of America Konsyl Orange (sugar free) Ispaghula husk 52% Powder, oral, bottles (325 g, 500 g) Powder, sachets (6.5 g) Konsyl Pharmaceuticals Inc., Easton, Maryland, United States of America Konsyl-D (flavour free) D(+)galactose 999 mg, palmitic acid 1 mg and water for injection (diluent) Granules, for suspension, vials; diluent, ampoules Schering AG, Berlin, Germany Levovist Recombinant Factor VIIa (human) 1.2 mg, 2.4 mg, 4.8 mg Powder for injection, vial Novo Nordisk A/S., Gentofte, Denmark NovoSeven Dated this 14th day of April 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.